8-K Announcements
6Material company update
May 7, 2026·SEC
Material company update
Mar 5, 2026·SEC
Material company update
Feb 5, 2026·SEC
Shattuck Labs, Inc.(STTK)Earnings, Financials & Key Ratios
STTK•NASDAQ
Price updated Jun 19, 2026
AboutShattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.Show more
- Revenue$1M-82.5%
- EBITDA-$48M+37.7%
- Net Income-$49M+35.3%
- EPS (Diluted)-0.70+53.0%
- Gross Margin100%
- EBITDA Margin-4782%-256.5%
- Operating Margin-5150.8%-265.8%
- Net Margin-4880.9%-270.3%
- ROE-60.25%+10.4%
STTK Key Insights
Shattuck Labs, Inc. (STTK) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Momentum leader: RS Rating 84 (top 16%)
✗Weaknesses
- ✗Negative free cash flow
- ✗Sales declining 36.8% over 5 years
- ✗Shares diluted 37.1% in last year
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when STTK posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
STTK Price & Volume
Shattuck Labs, Inc. (STTK) stock price & volume — 10-year historical chart
Loading chart...
STTK Growth Metrics
Shattuck Labs, Inc. (STTK) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-36.82%
3 Years15.32%
TTM-78.29%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM29.36%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM54.68%
Return on Capital
10 Years-43.93%
5 Years-49.68%
3 Years-62.66%
Last Year-62.02%
STTK Recent Earnings
Shattuck Labs, Inc. (STTK) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 8/12 qtrs (100%)
Q2 2026Latest
May 7, 2026Metric
Actual
Est
EPS
$0.13+7.1%
$0.14
Rev
—
—
Q2 2026
Mar 5, 2026Metric
Actual
Est
EPS
$0.12+0.0%
$0.12
Rev
—
$250,000
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$0.14+6.7%
$0.15
Rev
$1M+500.0%
$166,670
Q3 2025
Aug 14, 2025Metric
Actual
Est
EPS
$0.24+4.0%
$0.25
Rev
—
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.13vs $0.14+7.1% | — |
| Q2 2026 | Mar 5, 2026 | $0.12vs $0.12+0.0% | —vs $250,000 |
| Q4 2025 | Nov 6, 2025 | $0.14vs $0.15+6.7% | $1Mvs $166,670+500.0% |
| Q3 2025 | Aug 14, 2025 | $0.24vs $0.25+4.0% | — |
Based on last 12 quarters of dataView full earnings history →
STTK Peer Comparison
Shattuck Labs, Inc. (STTK) competitors in Oncology Therapeutics Developers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 RCUS | 2.45B | 24.31 | -7.39 | -4.26% | -156.36% | -68.97% | 0.16 | |
 IMVT | 7.26B | 35.34 | -12.76 | -68.16% | 0.00 | |||
 AGEN | 124.93M | 3.00 | -882.35 | 10.37% | 52.16% | |||
 NKTX | 204.62M | 2.86 | -2.03 | -30.9% | 0.24 | |||
 CRIS | 81.52M | 0.42 | -0.73 | -13.43% | -299.66% | -138.81% | 0.30 | |
 TGTX | 8.15B | 53.22 | 19.21 | 87.32% | 65.95% | 87.36% | 0.40 | |
 FATE | 243.61M | 2.09 | -1.82 | -51.24% | -20.57% | -58.89% | 0.38 | |
 ALNY | 37.1B | 278.09 | 119.35 | 65.19% | 13.46% | 98.29% | 1.62 |
Compare STTK vs Peers
Shattuck Labs, Inc. (STTK) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
STTK Income Statement
Shattuck Labs, Inc. (STTK) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 22.44M | 9.89M | 9.93M | 30.02M | 652K | 1.66M | 5.72M | 1M | 1M |
Revenue Growth % | - | -55.94% | 0.48% | 202.16% | -97.83% | 154.14% | 245.26% | -82.52% | -78.29% |
Cost of Goods Sold | 24.81M | 29.22M | 37.48M | 1.38M | 0 | 4.04M | 0 | 0 | 1.82M |
COGS % of Revenue | 110.54% | 295.52% | 377.32% | 4.6% | - | 243.93% | - | - | - |
Gross Profit | -2.37M▲ 0% | -19.33M▼ 717.4% | -27.55M▼ 42.5% | 28.64M▲ 203.9% | 652K▼ 97.7% | -2.38M▼ 465.8% | 5.72M▲ 339.9% | 1M▼ 82.5% | -820K▲ 0% |
Gross Margin % | -10.54% | -195.52% | -277.32% | 95.4% | 100% | -143.93% | 100% | 100% | -82% |
Gross Profit Growth % | - | -717.38% | -42.51% | 203.95% | -97.72% | -465.8% | 339.87% | -82.52% | - |
Operating Expenses | 28.59M | 5.74M | 9.38M | 73.91M | 103.98M | 89.57M | 86.29M | 52.51M | 51.84M |
OpEx % of Revenue | 127.4% | 58.02% | 94.44% | 246.21% | 15948.01% | 5405.67% | 1508.27% | 5250.8% | - |
Selling, General & Admin | 3.78M | 5.74M | 9.38M | 18.72M | 21.08M | 19.3M | 19.08M | 17.23M | 17.36M |
SG&A % of Revenue | 16.86% | 58.02% | 94.44% | 62.37% | 3233.44% | 1165% | 333.46% | 1723.5% | - |
Research & Development | 24.81M | 29.22M | 37.48M | 56.56M | 82.9M | 74.31M | 67.21M | 35.27M | 36.3M |
R&D % of Revenue | 110.54% | 295.52% | 377.32% | 188.44% | 12714.57% | 4484.61% | 1174.81% | 3527.3% | - |
Other Operating Expenses | -357K | -29.22M | -37.48M | -1.38M | 0 | -4.04M | 0 | 0 | -1.82M |
Operating Income | -6.15M▲ 0% | -25.07M▼ 307.7% | -36.93M▼ 47.3% | -45.27M▼ 22.6% | -103.33M▼ 128.3% | -91.96M▲ 11.0% | -80.57M▲ 12.4% | -51.51M▲ 36.1% | -52.66M▲ 0% |
Operating Margin % | -27.4% | -253.53% | -371.76% | -150.81% | -15848.01% | -5549.61% | -1408.27% | -5150.8% | -5266.4% |
Operating Income Growth % | - | -307.73% | -47.33% | -22.58% | -128.26% | 11.01% | 12.39% | 36.07% | - |
EBITDA | -5.89M | -24.53M | -36.31M | -43.89M | -100.26M | -87.92M | -76.74M | -47.82M | -49.02M |
EBITDA Margin % | -26.26% | -248.1% | -365.54% | -146.21% | -15376.69% | -5305.67% | -1341.34% | -4782% | -4902.1% |
EBITDA Growth % | - | -316.26% | -48.04% | -20.86% | -128.43% | 12.31% | 12.71% | 37.68% | 31.07% |
D&A (Non-Cash Add-back) | 255K | 537K | 618K | 1.38M | 3.07M | 4.04M | 3.83M | 3.69M | 3.64M |
EBIT | -4.76M | -25.07M | -36.93M | -45.27M | -103.33M | -91.96M | -80.57M | -51.51M | -51.43M |
Net Interest Income | -1.67M | 1.18M | 549K | 625K | 1.59M | 4.67M | 5.17M | 2.7M | 779K |
Interest Income | 966K | 1.18M | 549K | 625K | 1.59M | 4.67M | 5.17M | 2.7M | 779K |
Interest Expense | 2.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income/Expense | -1.24M | 1.08M | 328K | 295K | 1.38M | 4.66M | 5.16M | 2.7M | 2.79M |
Pretax Income | -7.39M▲ 0% | -23.98M▼ 224.6% | -36.6M▼ 52.6% | -44.97M▼ 22.9% | -101.94M▼ 126.7% | -87.3M▲ 14.4% | -75.41M▲ 13.6% | -48.81M▲ 35.3% | -49.87M▲ 0% |
Pretax Margin % | -32.92% | -242.56% | -368.46% | -149.83% | -15635.74% | -5268.44% | -1318.13% | -4880.9% | -4987.4% |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Net Income | -7.39M▲ 0% | -23.98M▼ 224.6% | -36.6M▼ 52.6% | -44.97M▼ 22.9% | -101.94M▼ 126.7% | -87.3M▲ 14.4% | -75.41M▲ 13.6% | -48.81M▲ 35.3% | -49.87M▲ 0% |
Net Margin % | -32.92% | -242.56% | -368.46% | -149.83% | -15635.74% | -5268.44% | -1318.13% | -4880.9% | -4987.4% |
Net Income Growth % | - | -224.61% | -52.63% | -22.87% | -126.68% | 14.37% | 13.62% | 35.28% | 29.36% |
Net Income (Continuing) | -7.39M | -23.98M | -36.6M | -44.97M | -101.94M | -87.3M | -75.41M | -48.81M | -49.87M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.49▲ 0% | -0.57▼ 16.3% | -0.88▼ 54.4% | -1.07▼ 21.6% | -2.41▼ 125.2% | -2.05▲ 14.9% | -1.49▲ 27.3% | -0.70▲ 53.0% | -0.44▲ 0% |
EPS Growth % | - | -16.33% | -54.39% | -21.59% | -125.23% | 14.94% | 27.32% | 53.02% | 54.68% |
EPS (Basic) | -0.49 | -0.57 | -0.88 | -1.07 | -2.41 | -2.05 | -1.49 | -0.70 | - |
Diluted Shares Outstanding | 15.04M | 41.74M | 41.77M | 42.03M | 42.38M | 42.6M | 50.76M | 69.58M | 112.23M |
Basic Shares Outstanding | 15.04M | 41.74M | 41.77M | 42.03M | 42.38M | 42.6M | 50.76M | 69.58M | 112.23M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
STTK Balance Sheet
Shattuck Labs, Inc. (STTK) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 65.63M | 42.44M | 345.64M | 288.27M | 184.58M | 143.22M | 79.22M | 82.47M | 93.75M |
Cash & Short-Term Investments | 60.38M | 39.09M | 335.45M | 268.8M | 161.28M | 130.63M | 72.99M | 78.06M | 90.42M |
Cash Only | 31.64M | 7.01M | 157.9M | 92.27M | 47.38M | 125.63M | 57.39M | 54.19M | 90.42M |
Short-Term Investments | 28.73M | 32.07M | 177.55M | 176.54M | 113.9M | 5M | 15.6M | 23.87M | 0 |
Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Sales Outstanding | - | - | - | - | - | - | - | - | - |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - | - | - | - |
Other Current Assets | 0 | 0 | 0 | 0 | 23.3M | 12.6M | 6.23M | 4.41M | 3.33M |
Total Non-Current Assets | 2.53M | 2.53M | 3.35M | 10.32M | 20.74M | 16.34M | 11.83M | 8.55M | 8.37M |
Property, Plant & Equipment | 2.5M | 2.44M | 3M | 9.94M | 17.67M | 13.8M | 9.81M | 6.11M | 5.35M |
Fixed Asset Turnover | 8.96x | 4.06x | 3.31x | 3.02x | 0.04x | 0.12x | 0.58x | 0.16x | 0.15x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1M | 1M |
Other Non-Current Assets | 23K | 90K | 349K | 381K | 3.07M | 2.54M | 2.02M | 1.44M | 3.02M |
Total Assets | 68.16M▲ 0% | 44.97M▼ 34.0% | 348.99M▲ 676.1% | 298.58M▼ 14.4% | 205.32M▼ 31.2% | 159.56M▼ 22.3% | 91.05M▼ 42.9% | 91.03M▼ 0.0% | 102.12M▲ 0% |
Asset Turnover | 0.33x | 0.22x | 0.03x | 0.10x | 0.00x | 0.01x | 0.06x | 0.01x | 0.01x |
Asset Growth % | - | -34.03% | 676.06% | -14.44% | -31.23% | -22.29% | -42.94% | -0.03% | -27.83% |
Total Current Liabilities | 20.85M | 19.98M | 16.83M | 24.59M | 24.96M | 11.45M | 8.92M | 7.05M | 4.25M |
Accounts Payable | 2.05M | 3.05M | 1.75M | 10.01M | 7.17M | 1.59M | 2.42M | 2.1M | 1.25M |
Days Payables Outstanding | 30.13 | 38.11 | 17.08 | 2.65K | - | 143.31 | - | - | 250.24 |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue (Current) | 17.04M | 12.89M | 7.73M | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 983K | 3.07M | 5.8M | 11.25M | 5.84M | 4.83M | 5.6M | 4.95M | 3M |
Current Ratio | 3.15x | 2.12x | 20.53x | 11.72x | 7.39x | 12.51x | 8.88x | 11.70x | 22.06x |
Quick Ratio | 3.15x | 2.12x | 20.53x | 11.72x | 7.39x | 12.51x | 8.88x | 11.70x | 22.06x |
Cash Conversion Cycle | - | - | - | - | - | - | - | - | - |
Total Non-Current Liabilities | 58.39M | 59.53M | 22.29M | 2.21M | 4.2M | 3.41M | 2.51M | 1.58M | 2.04M |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.58M | 2.04M |
Capital Lease Obligations | 0 | 0 | 0 | 0 | 4.2M | 3.41M | 2.51M | 0 | 2.02M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 50M | 49.96M | 987K | 2.21M | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 79.24M | 79.52M | 39.13M | 26.8M | 29.17M | 14.86M | 11.42M | 8.64M | 6.29M |
Total Debt | 0 | 0 | 0 | 0 | 4.9M | 4.2M | 3.41M | 1.58M | 2.04M |
Net Debt | -31.64M | -7.01M | -157.9M | -92.27M | -42.48M | -121.42M | -53.98M | -52.61M | -88.38M |
Debt / Equity | - | - | - | - | 0.03x | 0.03x | 0.04x | 0.02x | 0.02x |
Debt / EBITDA | - | - | - | - | - | - | - | - | -0.04x |
Net Debt / EBITDA | - | - | - | - | - | - | - | - | 1.80x |
Interest Coverage | -1.81x | - | - | - | - | - | - | - | - |
Total Equity | -11.08M▲ 0% | -34.55M▼ 211.8% | 309.86M▲ 996.9% | 271.79M▼ 12.3% | 176.16M▼ 35.2% | 144.71M▼ 17.9% | 79.63M▼ 45.0% | 82.39M▲ 3.5% | 95.83M▲ 0% |
Equity Growth % | - | -211.78% | 996.9% | -12.29% | -35.19% | -17.85% | -44.97% | 3.47% | -6.64% |
Book Value per Share | -0.74 | -0.83 | 7.42 | 6.47 | 4.16 | 3.40 | 1.57 | 1.18 | 0.85 |
Total Shareholders' Equity | -11.08M | -34.55M | 309.86M | 271.79M | 176.16M | 144.71M | 79.63M | 82.39M | 95.83M |
Common Stock | 1K | 1K | 5K | 5K | 5K | 5K | 5K | 7K | 7K |
Retained Earnings | -11.51M | -35.49M | -72.09M | -117.07M | -219.01M | -306.31M | -381.72M | -430.53M | -445.3M |
Treasury Stock | 0 | -887K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -49.06M | 54K | -63K | -560K | -877K | 4K | 2K | 6K | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
STTK Cash Flow Statement
Shattuck Labs, Inc. (STTK) cash flow — operating, investing & free cash flow history
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -6.9M | -20.98M | -33.66M | -57.12M | -94.5M | -81.23M | -60.52M | -39.88M | -41.27M |
Operating CF Margin % | -30.76% | -212.15% | -338.83% | -190.28% | -14493.56% | -4902.11% | -1057.77% | -3988.2% | - |
Operating CF Growth % | - | -203.85% | -60.47% | -69.69% | -65.45% | 14.04% | 25.5% | 34.1% | 88.44% |
Net Income | -7.39M | -23.98M | -36.6M | -44.97M | -101.94M | -87.3M | -75.41M | -48.81M | -49.87M |
Depreciation & Amortization | 255K | 537K | 618K | 1.38M | 3.07M | 4.04M | 3.83M | 3.69M | 3.64M |
Stock-Based Compensation | 425K | 461K | 1.27M | 5.47M | 6.46M | 6.94M | 9.55M | 7M | 5.91M |
Deferred Taxes | -404K | 0 | 1K | 3.04M | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 2.71M | -207K | 89K | 1.52M | 2.38M | -816K | -1.5M | -971K | 1.46M |
Working Capital Changes | -2.5M | 2.22M | 970K | -23.55M | -4.46M | -4.09M | 3.02M | -785K | -2.42M |
Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | 1.12M | 1M | -1.75M | 7.87M | -2.84M | -5.63M | 832K | -318K | -1.03M |
Cash from Investing | -29.93M | -3.59M | -146.32M | -10.44M | 49.44M | 110.86M | -8.51M | -7.89M | 361K |
Capital Expenditures | -1.18M | -470K | -727K | -7.93M | -11.61M | -407K | -59K | -71K | -8K |
CapEx % of Revenue | 5.25% | 4.75% | 7.32% | 26.41% | 1781.29% | 24.56% | 1.03% | 7.1% | 0.8% |
Acquisitions | 0 | 0 | 145.59M | 2.52M | 104K | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - |
Other Investing | -15K | 0 | -145.59M | -2.52M | 0 | 0 | 0 | 0 | -43.48M |
Cash from Financing | 35.15M | -64K | 330.87M | 1.93M | 171K | 48.62M | 787K | 44.57M | 70.43M |
Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Equity Issued (Net) | 35.3M | 0 | 349.92M | 1.93M | 171K | 48.67M | -17K | 44.64M | 26.2M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | -152K | -64K | -19.05M | 0 | 0 | -53K | 804K | -65K | 44.23M |
Net Change in Cash | -1.68M▲ 0% | -24.63M▼ 1363.5% | 150.88M▲ 712.6% | -65.63M▼ 143.5% | -44.89M▲ 31.6% | 78.25M▲ 274.3% | -68.24M▼ 187.2% | -3.19M▲ 95.3% | 29.52M▲ 0% |
Free Cash Flow | -8.08M▲ 0% | -21.45M▼ 165.4% | -34.39M▼ 60.3% | -65.04M▼ 89.2% | -106.11M▼ 63.1% | -81.64M▲ 23.1% | -60.57M▲ 25.8% | -39.95M▲ 34.0% | -41.28M▲ 0% |
FCF Margin % | -36.01% | -216.9% | -346.14% | -216.68% | -16274.85% | -4926.67% | -1058.8% | -3995.3% | -4128.2% |
FCF Growth % | - | -165.38% | -60.35% | -89.15% | -63.14% | 23.07% | 25.8% | 34.04% | 26.86% |
FCF per Share | -0.54 | -0.51 | -0.82 | -1.55 | -2.50 | -1.92 | -1.19 | -0.57 | -0.37 |
FCF Conversion (FCF/Net Income) | 0.93x | 0.87x | 0.92x | 1.27x | 0.93x | 0.93x | 0.80x | 0.82x | 0.83x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
STTK Key Ratios
Shattuck Labs, Inc. (STTK) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | - | -26.59% | -15.46% | -45.52% | -54.41% | -67.23% | -60.25% | -60.73% |
Return on Invested Capital (ROIC) | - | -50.18% | -20.48% | -49.49% | -87.88% | -247.01% | -139.39% | -159.25% |
Gross Margin | -195.52% | -277.32% | 95.4% | 100% | -143.93% | 100% | 100% | -82% |
Net Margin | -242.56% | -368.46% | -149.83% | -15635.74% | -5268.44% | -1318.13% | -4880.9% | -4987.4% |
Debt / Equity | - | - | - | 0.03x | 0.03x | 0.04x | 0.02x | 0.02x |
FCF Conversion | 0.87x | 0.92x | 1.27x | 0.93x | 0.93x | 0.80x | 0.82x | 0.83x |
Revenue Growth | -55.94% | 0.48% | 202.16% | -97.83% | 154.14% | 245.26% | -82.52% | -78.29% |
Related:STTK Dividend History·STTK Revenue History·STTK Price History·STTK P/E History·STTK Financial Ratios·STTK Institutional Holders
STTK SEC Filings & Documents
Shattuck Labs, Inc. (STTK) SEC filings — annual & quarterly reports (10-K, 10-Q)
STTK Frequently Asked Questions
Shattuck Labs, Inc. (STTK) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Shattuck Labs, Inc. (STTK) reported $1.0M in revenue for fiscal year 2025. This represents a 96% decrease from $22.4M in 2018.
Shattuck Labs, Inc. (STTK) saw revenue decline by 82.5% over the past year.
Shattuck Labs, Inc. (STTK) reported a net loss of $49.9M for fiscal year 2025.
Dividend & Returns
Shattuck Labs, Inc. (STTK) has a return on equity (ROE) of -60.3%. Negative ROE indicates the company is unprofitable.
Shattuck Labs, Inc. (STTK) had negative free cash flow of $41.3M in fiscal year 2025, likely due to heavy capital investments.